Table 1.
Stage-specific incidence rate, tumor size, lymph node involvements, and distant metastasis of breast tumors diagnosed in invited participants and invited non-participants in the Norwegian Breast Cancer Screening Program 1996–2007
All tumors | 1,925,725 biennial invitations sent to 640,347 women between 1996 and 2007 |
||||||
---|---|---|---|---|---|---|---|
All invitations n = 1,925,725 |
Invited participants n = 1,475,978 |
Invited non-participants n = 449,747 |
Rate ratio |
||||
N | Rate per 100,000 invitations |
N | Rate per 100,000 invitations |
N | Rate per 100,000 invitations |
Participants/non- participants |
|
Stage | |||||||
0 (DCIS) | 1,670 | 86.7 | 1,517 | 102.8 | 153 | 34.0a | 3.0 |
I | 5,885 | 305.5 | 5,105 | 345.9 | 780 | 173.4a | 2.0 |
II | 3,552 | 184.4 | 2,845 | 192.8 | 707 | 157.2a | 1.2 |
III | 173 | 9.0 | 108 | 7.3 | 65 | 14.5a | 0.5 |
IV | 272 | 14.1 | 134 | 9.1 | 138 | 30.7a | 0.3 |
Missing/not available | 17 | 0.9 | 17 | 1.1 | – | – | – |
All | 11,569 | 600.6 | 9,726 | 659.0 | 1,843 | 409.8a | 1.6 |
| |||||||
Invasive tumors | n = 9,899 | n = 8,209 | n = 1,690 | ||||
| |||||||
Tumor size | |||||||
≤20 mm | 6,364 | 330.5 | 5,573 | 377.6 | 791 | 175.9a | 2.1 |
>20 and ≤50 mm | 1,854 | 96.3 | 1,431 | 97.0 | 423 | 94.1 | 1.0 |
>50 mm | 334 | 17.4 | 198 | 13.4 | 136 | 30.2a | 0.7 |
Missing/ not available |
1,347 | 69.9 | 1,007 | 68.2 | 340 | 75.6 | – |
Lymph node involvements | |||||||
No | 6,158 | 319.8 | 5,331 | 362.2 | 827 | 183.9a | 2.0 |
Yes | 3,013 | 156.5 | 2,376 | 161.0 | 637 | 141.6a | 1.1 |
Missing/not available | 728 | 37.8 | 502 | 34.0 | 226 | 50.3 | – |
Distant metastasis | |||||||
No | 7,465 | 387.6 | 6,370 | 431.6 | 1,095 | 243.2a | 1.8 |
Yes | 267 | 13.9 | 132 | 8.9 | 135 | 30.0a | 0.3 |
Missing/ not available |
2,167 | 112.5 | 1,707 | 115.7 | 460 | 102.3 | – |
p value <0.05 for Chi-squared between the groups “Invited Participants” and “Invited Non-participants”